Non-invasive fluorescent imaging of gliosis in transgenic mice for profiling developmental neurotoxicity

Toxicology and Applied Pharmacology

Volumn 221, Issue 1, 2007, Pages 76-85

  Ho, Gideon ^a   Zhang, Chunyan ^a   Zhuo, Lang ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Compound screening; Developmental neurotoxicology; GFAP; Gliosis; Non invasive imaging

Indexed keywords

1 METHYL4 (2' METHYLPHENYL) 1,2,3,6 TETRAHYDROPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; KAINIC ACID; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEGENERATIVE DISEASE; GLIOSIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROPATHY; NEUROTOXICITY; NEWBORN; NONHUMAN; PARKINSON DISEASE; POSTNATAL DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CEREBRAL VENTRICLES; DIAGNOSTIC IMAGING; EXCITATORY AMINO ACID AGONISTS; FLUORESCENCE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEUROTOXICITY SYNDROMES; NEUROTOXINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS; MUS MUSCULUS;

EID: 34248144530     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.01.023     Document Type: Article

References (38)

1. Abdel-Wahab M.H. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity - induced by 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-methyl-MPTP) in mice. J. Biochem. Mol. Toxicol. 19 (2005) 32-41
2. Ali S.F., David S.N., and Newport G.D. Age-related susceptibility to MPTP-induced neurotoxicity in mice. Neurotoxicology 14 (1993) 29-34
3. Andersen H.R., Nielsen J.B., and Grandjean P. Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology 144 (2000) 121-127
4. Barone Jr. S., Haykal-Coates N., Parran D.K., and Tilson H.A. Gestational exposure to methylmercury alters the developmental pattern of trk-like immunoreactivity in the rat brain and results in cortical dysmorphology. Dev. Brain Res. 109 (1998) 13-31
5. Benkovic S.A., O'Callaghan J.P., and Miller D.B. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Res. 1024 (2004) 59-76
6. Bloem B.R., Irwin I., Buruma O.J.S., Haan J., Roos R.A.C., Tetrud J.W., and Langston J.W. The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J. Neurol. Sci. 97 (1990) 273-293
7. Bondy S.C., and Campbell A. Mini-review: developmental neurotoxicology. J. Neurosci. Res. 81 (2005) 605-612
8. Brenner M., Kisserberth W.C., Su Y., and Besnard F. GFAP promotor directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14 (1994) 1030-1037
9. Brown T.P., Rumsby P.C., Capleton A.C., Rushton L., and Levy L.S. Pesticides and Parkinson's disease - is there a link?. Environ. Health Perspect. 114 (2006) 156-164
10. Chen L.W., Wei L.C., Qiu Y., Liu H.L., R R.Z., Ju G., and Chan Y.S. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice. Are the striatal astrocytes regionally activated after systemic MPTP administration?. Brain Res. 925 (2002) 9-17
11. Claudio L., Kwa W.C., Russell A.L., and Wallinga D. Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol. Appl. Pharmacol. 164 (2000) 1-14
12. Cory-Slechta D.A., Thiruchelvam M., Richfield E.K., Barlow B.K., and Brooks A.I. Developmental pesticide exposures and the Parkinson's disease phenotype. Birth Defects Res., Part A: Clin. Mol. Teratol. 73 (2005) 136-139
13. Costa L.G., Aschner M., Vitalone A., Syversen T., and Soldin O.P. Developmental neuropathology of environmental agents. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 87-110
14. European, C., 2003. Proposal for a regulation of the European Parliament and of the council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). COM 0644.
15. Fields R.D., and Stevens-Graham B. New insights into neuron-glia communication. Science 298 (2002) 556-562
16. Flint Beal M. Experimental models of Parkinson's disease. Nat. Rev., Neurosci. 2 (2001) 325-332
17. Franklin K., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, London
18. Fredriksson A., Fredriksson M., and Eriksson P. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice. Toxicol. Appl. Pharmacol. 122 (1993) 258-264
19. Garcia S.J., Seidler F.J., Qiao D., and Slotkin T.A. Chlorpyrifos targets developing glia: effects on glial fibrillary acidic protein. Dev. Brain Res. 133 (2002) 151-161
20. Hass U. Current status of developmental neurotoxicity: regulatory view. Toxicol. Lett. 140-141 (2003) 155-159
21. Kaufmann W. Current status of developmental neurotoxicity: an industry perspective. Toxicol. Lett. 140-141 (2003) 161-169
22. Kurosaki R., Muramatsu Y., Kato H., and Araki T. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. Pharmacol. Biochem. Behav. 78 (2004) 143-153
23. Liebert A., Wabnitz H., Obrig H., Erdmann R., Moller M., MacDonald R., Rinneberg H., Villringer A., and Steinbrink J. Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain. NeuroImage 31 (2006) 600-608
24. Milenkovic I., Nedeljkovic N., Filipovic R., Pekovic S., Culic M., Rakic L., and Stojiljkovic M. Pattern of glial fibrillary acidic protein expression following kainate-induced cerebellar lesion in rats. Neurochem. Res. 30 (2005) 207-213
25. O'Callaghan J.P. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 10 (1988) 445-452
26. Ochi N., Naoi M., Mogi M., Ohya Y., Mizutani N., Watanabe K., Harada M., and Nagatsu T. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain. Life Sci. 48 (1991) 217-223
27. Ostergren A., Fredriksson A., and Brittebo E.B. Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra. J. Neural Transm. 113 (2006) 313-329
28. Pogge A., and Slikker W. Neuroimaging: new approaches for neurotoxicology. Neurotoxicology 25 (2004) 525-531
29. Reinhard J.F.J., Miller D.B., and O'Callaghan J.P. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Neurosci. Lett. 95 (1988) 246-251
30. Rice B.W., Cable M.D., and Nelson M.B. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6 (2001) 432-440
31. Scallet A.C., Schmued L.C., Slikker W., Grunberg N., Faustino P.J., Davis H., Lester D., Pine P.S., Sistare F., and Hanig J.P. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 81 (2004) 364-370
32. Schwartz J.P., and Nishiyama N. Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 35 (1994) 403-407
33. Smeyne R.J., and Jackson-Lewis V. The MPTP model of Parkinson's disease. Mol. Brain Res. 134 (2005) 57-66
34. Su M., Hu H., Lee Y., d'Azzo A., Messing A., and Brenner M. Expression specificity of GFAP transgenes. Neurochem. Res. 29 (2004) 2075-2093
35. Tilson H.A. The role of developmental neurotoxicology studies in risk assessment. Toxicol. Pathol. 28 (2000) 149-156
36. Yang M., Baranov E., Jiang P., Sun F.X., Li X.M., Li L., Hasegawa S., Bouvet M., Al-Tuwaijri M., Chishima T., Shimada H., Moossa A.R., Penman S., and Hoffman R.M. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1206-1211
37. Zhang C.Y., and Zhuo L. EGCG and genistein attenuate GFAP elevation induced by fibrogenic cytokines in hepatic stellate cells. Int. J. Mol. Med. 18 (2006) 1141-1151
38. Zhuo L., Sun B., Zhang C.L., Fine A., Chiu S.Y., and Messing A. Live astrocytes visualized by green fluorescent protein in transgenic mice. Dev. Biol. 187 (1997) 36-42